The heightened expression of dihydropyrimidine dehydrogenase (DPYD) in pancreatic cancer not only accelerates pyrimidine degradation but also stimulates cell proliferation and invasiveness, accompanied by the upregulation of MMP9 and MEP1A. This evidence concerns the gene MEP1A and familial pancreatic carcinoma.